Mike Aylott

844 total citations
15 papers, 673 citations indexed

About

Mike Aylott is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Mike Aylott has authored 15 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Cancer Research. Recurrent topics in Mike Aylott's work include Cardiac electrophysiology and arrhythmias (4 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Animal testing and alternatives (2 papers). Mike Aylott is often cited by papers focused on Cardiac electrophysiology and arrhythmias (4 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Animal testing and alternatives (2 papers). Mike Aylott collaborates with scholars based in United Kingdom, United States and Belgium. Mike Aylott's co-authors include Kate Harris, James B. Louttit, Arun Sridhar, Yi Cui, Pauline Williams, Jonathan Bullman, Jonathan Appleby, Robert Lai, Boris A. Chizh and Antonella Napolitano and has published in prestigious journals such as Pain, Toxicological Sciences and Journal of Pain.

In The Last Decade

Mike Aylott

15 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Aylott United Kingdom 11 286 154 146 145 140 15 673
Eduardo Rosenmann Canada 12 453 1.6× 264 1.7× 38 0.3× 186 1.3× 358 2.6× 27 884
Ellen J. Lehning United States 21 309 1.1× 350 2.3× 27 0.2× 128 0.9× 14 0.1× 41 1.4k
Pascal Champéroux France 18 333 1.2× 104 0.7× 344 2.4× 153 1.1× 10 0.1× 53 904
Bo Zeng China 16 353 1.2× 120 0.8× 33 0.2× 71 0.5× 370 2.6× 35 735
Emel Songu‐Mize United States 17 514 1.8× 129 0.8× 186 1.3× 208 1.4× 51 0.4× 40 1.0k
Haijie Yu United States 15 337 1.2× 87 0.6× 56 0.4× 65 0.4× 71 0.5× 29 677
Mary Louise Roy United States 12 716 2.5× 243 1.6× 531 3.6× 53 0.4× 20 0.1× 15 1.0k
Pritam Sinharoy United States 14 140 0.5× 33 0.2× 58 0.4× 74 0.5× 164 1.2× 21 422
Elena S. Trepakova United States 14 779 2.7× 300 1.9× 372 2.5× 172 1.2× 328 2.3× 17 1.1k

Countries citing papers authored by Mike Aylott

Since Specialization
Citations

This map shows the geographic impact of Mike Aylott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Aylott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Aylott more than expected).

Fields of papers citing papers by Mike Aylott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Aylott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Aylott. The network helps show where Mike Aylott may publish in the future.

Co-authorship network of co-authors of Mike Aylott

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Aylott. A scholar is included among the top collaborators of Mike Aylott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Aylott. Mike Aylott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Milliken, Philip H., Mike Aylott, Steven K. Engle, et al.. (2020). Evaluating Associations Between Nonclinical Cardiovascular Functional Endpoints and Repeat-dose Cardiovascular Toxicity in the Beagle Dog: A Cross-company Initiative. Toxicological Sciences. 176(1). 224–235. 4 indexed citations
2.
Rowley, Tania F., Mike Aylott, Robert Griffin, et al.. (2018). Engineered hexavalent Fc proteins with enhanced Fc-gamma receptor avidity provide insights into immune-complex interactions. Communications Biology. 1(1). 146–146. 20 indexed citations
3.
Ewart, Lorna, Mike Aylott, Mark Deurinck, et al.. (2014). The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative. Toxicological Sciences. 142(2). 427–435. 53 indexed citations
4.
Stegemann, Sven, Paul Connolly, W. Stephen Matthews, et al.. (2014). Application of QbD Principles for the Evaluation of Empty Hard Capsules as an Input Parameter in Formulation Development and Manufacturing. AAPS PharmSciTech. 15(3). 542–549. 11 indexed citations
5.
Harris, Kate, et al.. (2013). Comparison of Electrophysiological Data From Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes to Functional Preclinical Safety Assays. Toxicological Sciences. 134(2). 412–426. 178 indexed citations
6.
Ewart, Lorna, Hamid Amouzadeh, Mike Aylott, et al.. (2013). Analysis of concordance of nonclinical rodent respiratory function measurements to phase i trial outcome using the animal model framework. Journal of Pharmacological and Toxicological Methods. 68(1). e42–e43. 1 indexed citations
7.
Reus, Astrid, Julia Kenny, Peter Clements, et al.. (2012). The in vivo rat skin photomicronucleus assay: phototoxicity and photogenotoxicity evaluation of six fluoroquinolones. Mutagenesis. 27(6). 721–729. 17 indexed citations
8.
Jarvis, Philip, et al.. (2011). An assessment of the statistical methods used to analyse toxicology studies. Pharmaceutical Statistics. 10(6). 477–484. 6 indexed citations
9.
Lynch, Anthony M., Amanda Giddings, Laura Custer, et al.. (2011). International Pig‐a gene mutation assay trial (Stage III): Results with N‐methyl‐N‐nitrosourea. Environmental and Molecular Mutagenesis. 52(9). 699–710. 38 indexed citations
10.
Bright, Jonathan, Mike Aylott, Simon T. Bate, et al.. (2011). Recommendations on the statistical analysis of the Comet assay. Pharmaceutical Statistics. 10(6). 485–493. 49 indexed citations
11.
Aylott, Mike, et al.. (2010). Review of the statistical analysis of the dog telemetry study. Pharmaceutical Statistics. 10(3). 236–249. 22 indexed citations
12.
Chizh, Boris A., Antonella Napolitano, Jie Wang, et al.. (2007). The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain. 132(1). 132–141. 199 indexed citations
13.
Chizh, B.A., Antonio Napolitano, Mike O’Donnell, et al.. (2006). (765). Journal of Pain. 7(4). S42–S42. 10 indexed citations
14.
15.
George, Elisabeth, et al.. (1999). Comparison of Hepatocyte Cultures and Liver Slices in In Vitro Toxicity Testing. Alternatives to Laboratory Animals. 27(5). 769–781. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduardo Rosenmann Breakdown of academic impact, for papers by Ellen J. Lehning Breakdown of academic impact, for papers by Pascal Champéroux Breakdown of academic impact, for papers by Bo Zeng Breakdown of academic impact, for papers by Emel Songu‐Mize Breakdown of academic impact, for papers by Haijie Yu Breakdown of academic impact, for papers by Mary Louise Roy Breakdown of academic impact, for papers by Pritam Sinharoy Breakdown of academic impact, for papers by Elena S. Trepakova
Rankless by CCL
2026